Aardvark Therapeutics price objective cut to $1.5 from $4
AARD•BofA Global Research cut its price objective for Aardvark Therapeutics to $1.5 from $4.
Related News
BofA Global Research cuts Booz Allen Hamilton price objective to $68 from $75
BAH•
Eagle Bancorp target price raised to $34 from $29
EGBN•
GE Aerospace: Jefferies cuts target price to $425 from $435
GE•
1st Source Corporation: KBW raises target price to $92 from $82
SRCE•
Biocon signs Janssen licensing deal for Yesintek in nine additional markets
JNJ•